Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Multi-Omics Refines the Molecular Subtypes of Thyroid Cancers and Enhances Cancer-Progression Prediction

NCT06969768 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06969768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06969768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Multi-Omics Refines the Molecular Subtypes of Thyroid Cancers and Enhances Cancer-Progression Prediction
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
February 21, 2018
Completion date
February 28, 2024
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer